IRIS

1.1 Articolo in rivista: [26851] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 6.901 a 6.920 di 26.851
Titolo Data di pubblicazione Autore(i) File
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 1-gen-2020 Gremese, E.; Ferraccioli, E. S.; Alivernini, S.; Tolusso, B.; Ferraccioli, G.
QT and QT dispersion intervals in long-standing and moderately active rheumatoid arthritis: results from a multicentre cross-sectional study 1-gen-2020 Erre, Gian Luca; Piras, Alessandra; Piga, Matteo; Fedele, Anna L; Mangoni, Arduino A; Lazzerini, Pietro E; Gremese, Elisa; Mathieu, Alessandro; Ferraccioli, Gianfranco; Passiu, Giuseppe; Saba, Pier S
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial 1-gen-2020 Khanna, D; Lin, Cjf; Furst, De; Goldin, J; Kim, G; Kuwana, M; Allanore, Y; Matucci-Cerinic, M; Distler, O; Shima, Y; van Laar, Jm; Spotswood, H; Gremese, E; Wagner, B; Siegel, J; Jahreis, A; Denton, Cp
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 1-gen-2021 Bruno, D.; Fedele, A. L.; Tolusso, B.; Barini, A.; Petricca, L.; Di Mario, C.; Barini, A.; Mirone, L.; Ferraccioli, G.; Alivernini, S.; Gremese, E.
Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end? 1-gen-2020 Landi, F.; Gremese, E.; Rota, E.; Carfi, A.; Benvenuto, F.; Ciciarello, F.; Lo Monaco, M. R.; Martone, A. M.; Pagano, F.; Paglionico, A.; Petricca, L.; Rocchi, S.; Tritto, M.; Sanguinetti, M.; Bernabei, R.
Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics’ register GISEA 1-gen-2018 Iannone, F.; Ferraccioli, G.; Sinigaglia, L.; Favalli, E. G.; Sarzi-Puttini, P.; Atzeni, F.; Gorla, R.; Bazzani, C.; Govoni, M.; Farina, I.; Gremese, E.; Carletto, A.; Giollo, A.; Galeazzi, M.; Foti, R.; Bianchino, L.; La Grasta, L.; Lapadula, G.
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors 1-gen-2012 Iannone, F; Gremese, E; Atzeni, F; Biasi, D; Botsios, C; Cipriani, P; Ferri, C; Foschi, V; Galeazzi, M; Gerli, R; Giardina, A; Marchesoni, A; Salaffi, F; Ziglioli, T; Lapadula, G; Gruppo Italiano di Studio sulle Early Arthritides, (GISEA).
Benefit/risk of cyclosporine in rheumatoid arthritis 1-gen-2004 Gremese, E; Ferraccioli, Gf
Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis 1-gen-2011 Ferraccioli, Gianfranco; Gremese, Elisa
Biomarkers of joint damage in rheumatoid arthritis: where are we in 2013? 1-gen-2013 Ferraccioli, Gianfranco; Alivernini, Stefano; Gremese, Elisa
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 1-gen-2022 Perniola, Simone; Bizzoca, Rita; Fornaro, Marco; Alivernini, Stefano; Gremese, Elisa; Iannone, Florenzo
Residual minimal disease activity in rheumatoid arthritis: a simple definition through an in-depth statistical analysis of the major outcome 1-gen-2009 Pietrapertosa, D; Salaffi, F; Peluso, G; Bosello, Sl; Fedele, Al; Cuoghi, I; Michelutti, A; Gremese, E; Ferraccioli, Gf
Basophil activation and serum IL-5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti-IL-5 drugs 1-gen-2021 Caruso, C.; Colantuono, S.; Tolusso, B.; Di Mario, C.; Pentassuglia, A.; Rumi, G.; Gremese, E.; Romano, A.; Gasbarrini, A.
Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis 1-gen-2010 Ferraccioli, G; BRACCI-LAUDIERO, L; Alivernini, S; Gremese, E; Tolusso, B; De, ; Benedetti, F
Incidence of cancer in patients with spondyloarthritis treated with anti-TNF drugs 1-gen-2017 Atzeni, F; Carletto, A; Foti, R; Sebastiani, M; Panetta, V; Salaffi, F; Bonitta, G; Iannone, F; Gremese, E; Govoni, M; Marchesoni, A; Favalli, Eg; Gorla, R; Ramonda, R; Sarzi-Puttini, P; Ferraccioli, G; Lapadula, G; Gisea, Group.
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 1-gen-2012 Frezza, D; Tolusso, Barbara; Giambra, V; Gremese, Elisa; Marchini, M; Nowik, M; Serone, E; D'Addabbo, P; Mattioli, C; Canestri, S; Petricca, L; D'Antona, G; Birshtein, Bk; Scorza, R; Ferraccioli, Gianfranco
Definition of fibromyalgia severity: Findings from a cross-sectional survey of 2339 Italian patients 1-gen-2021 Salaffi, F.; Di Carlo, M.; Bazzichi, L.; Atzeni, F.; Govoni, M.; Biasi, G.; Di Franco, M.; Mozzani, F.; Gremese, E.; Dagna, L.; Batticciotto, A.; Fischetti, F.; Giacomelli, R.; Guiducci, S.; Guggino, G.; Bentivegna, M.; Gerli, R.; Salvarani, C.; Bajocchi, G.; Ghini, M.; Iannone, F.; Giorgi, V.; Farah, S.; Cirillo, M.; Bonazza, S.; Barbagli, S.; Gioia, C.; Santilli, D.; Capacci, A.; Cavalli, G.; Carubbi, F.; Nacci, F.; Riccucci, I.; Sinigaglia, L.; Masullo, M.; Polizzi, B. M.; Cutolo, M.; Sarzi-Puttini, P.
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression 1-gen-2018 Bosello, S; Angelucci, C; Lama, G; Alivernini, S; Proietti, G; Tolusso, B; Sica, G; Gremese, E; Ferraccioli, G.
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons 1-gen-2017 Alivernini, S; Galeazzi, M; Peleg, H; Tolusso, B; Gremese, E; Ferraccioli, G; Naparstek, Y.
Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement 1-gen-2015 Simone, Davide; Nowik, Marcin; Gremese, Elisa; Ferraccioli, Gianfranco
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 6.901 a 6.920 di 26.851
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista26851
Autore
  • OYEN, Willem Jozef Gerard891
  • SANTORO, Armando806
  • CANONICA, Giorgio775
  • REPICI, Alessandro722
  • HASSAN, CESARE690
  • DANESE, Silvio643
  • FASANO, ALFONSO471
  • Marcacci, Maurilio467
  • D'INCALCI, MAURIZIO466
  • LAGHI, ANDREA456
Data di pubblicazione
  • In corso di stampa6
  • 2020 - 20269055
  • 2010 - 201911532
  • 2000 - 20094500
  • 1990 - 19991429
  • 1980 - 1989306
  • 1975 - 197923
Editore
  • Edition AERCV1
  • Elsevier1
  • Futura Publishing Company1
  • Grafica Luigi Monti s.r.l.1
  • Karger, Basel1
  • Mosby1
  • sn1
  • Springer-Verlag1
  • Thieme1
Rivista
  • DIGESTIVE AND LIVER DISEASE368
  • EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
  • ANNALS OF ONCOLOGY243
  • CANCERS226
  • THE JOURNAL OF NUCLEAR MEDICINE220
  • PLOS ONE212
  • EUROPEAN JOURNAL OF CANCER205
  • GASTROINTESTINAL ENDOSCOPY193
  • JOURNAL OF CLINICAL MEDICINE181
  • ALLERGY180
Keyword
  • Humans2101
  • Female1005
  • Male964
  • Middle Aged745
  • Aged643
  • Adult550
  • COVID-19414
  • Treatment Outcome359
  • Animals321
  • Retrospective Studies262
Lingua
  • eng19132
  • ita408
  • spa13
  • fre11
  • ger8
  • enm3
  • por2
  • chi1
Accesso al fulltext
  • no fulltext24598
  • reserved1362
  • open891